This announcement is a separate document:
華領醫藥-B：自願性公告 - 全球首創新藥葡萄糖激酶激活劑华堂宁獲納入2023年國家醫保藥品目錄
HUA MEDICINE-B: VOLUNTARY ANNOUNCEMENT - INNOVATIVE FIRST-IN-CLASS GKA, HUATANGNING INCLUDED IN THE 2023 NATIONAL REIMBURSEMENT DRUG LIST
The translation is provided by third-party software.
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.